1h-imidazo(4,5-b)pyridine has been researched along with Psychotic Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arrington, K; Dudkin, V; Fillgrove, KL; Garbaccio, RM; Hartingh, TJ; Huszar, SL; Jacobson, MA; Kelly, MJ; Kuo, Y; Layton, ME; Magliaro, BC; O'Brien, JA; Reif, AJ; Rodzinak, K; Tang, C; Uslaner, JM; Wang, C | 1 |
1 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Psychotic Disorders
Article | Year |
---|---|
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Topics: Allosteric Regulation; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Imidazoles; Locomotion; Protein Binding; Psychotic Disorders; Pyridines; Pyridones; Rats; Receptors, Metabotropic Glutamate; Structure-Activity Relationship | 2016 |